Advertisement

Schizophrenia and 22q11.2 deletion syndrome

  • Anne S. BassettEmail author
  • Eva W.C. Chow
Article

Abstract

22q11.2 deletion syndrome (22qDS) is a genetic syndrome associated with a chromosome 22q11.2 deletion and variable phenotypic expression that commonly includes schizophrenia. Approximately 1% of patients with schizophrenia have 22qDS. The schizophrenia in 22qDS appears broadly similar to that found in the general population with respect to core signs and symptoms, treatment response, neurocognitive profile, and MRI brain anomalies. However, individuals with a 22qDS form of schizophrenia typically have distinguishable physical features, have a lower IQ, and may differ in auxiliary clinical features. IQ, length of 22q11.2 deletions, and COMT functional allele do not appear to be major risk factors for schizophrenia in 22qDS. Ascertainment biases and small sample sizes are limitations of most studies. Larger studies over the lifespan and continuing education about this underrecognized condition are needed. 22qDS-schizophrenia is an important genetic subtype and a valuable model of neurodevelopmental mechanisms involved in the pathogenesis of schizophrenia.

Keywords

Schizophrenia Biol Psychiatry Schizoaffective Disorder 22q11 Deletion Deletion Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Bassett AS, Chow EW, Hodgkinson KA: Schizophrenia and psychotic disorders. In Psychiatric Genetics: Applications in Clinical Practice. Edited by Smoller JW, Sheidley BR, Tsuang MT. Arlington, VA: American Psychiatric Publishing, Inc.; 2008, In press.Google Scholar
  2. 2.
    Bassett AS, Chow EW, Husted J, et al.: Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A 2005, 138:307–313.PubMedGoogle Scholar
  3. 3.
    Bassett AS, Chow EW: 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999, 46:882–891.PubMedCrossRefGoogle Scholar
  4. 4.
    Weksberg R, Stachon AC, Squire JA, et al.: Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome. Hum Genet 2007, 120:837–845.PubMedCrossRefGoogle Scholar
  5. 5.
    Goodship J, Cross I, LiLing J, Wren C: A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 1998, 79:348–351.PubMedGoogle Scholar
  6. 6.
    Bassett AS, Chow EW, Weksberg R: Chromosomal abnormalities and schizophrenia. Am J Med Genet 2000, 97C:45–51.CrossRefGoogle Scholar
  7. 7.
    Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940–945.PubMedCrossRefGoogle Scholar
  8. 8.
    Pulver AE, Karayiorgou M, Wolyniec PS, et al.: Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12–13.1: Part 1. Am J Med Genet 1994, 54:36–43.PubMedCrossRefGoogle Scholar
  9. 9.
    Hodgkinson K, Murphy J, O’Neill S, et al.: Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry 2001, 46:123–130.PubMedGoogle Scholar
  10. 10.
    Sporn A, Addington A, Reiss AL, et al.: 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry 2004, 9:225–226.PubMedCrossRefGoogle Scholar
  11. 11.
    Gothelf D, Frisch A, Munitz H, et al.: Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 1999, 35:105–112.PubMedCrossRefGoogle Scholar
  12. 12.
    Bassett AS, Chow EW, AbdelMalik P, et al.: The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 2003, 160:1580–1586.PubMedCrossRefGoogle Scholar
  13. 13.
    Gothelf D, Feinstein C, Thompson T, et al.: Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 2007, 164:663–669.PubMedCrossRefGoogle Scholar
  14. 14.
    Bassett AS, Hodgkinson K, Chow EW, et al.: 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998, 81:328–337.PubMedCrossRefGoogle Scholar
  15. 15.
    Aneja A, Fremont WP, Antshel KM, et al.: Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). J Child Adolesc Psychopharmacol 2007, 17:105–114.PubMedCrossRefGoogle Scholar
  16. 16.
    Bassett AS, Caluseriu O, Wong V, et al.: Hypocalcemia and the neuropsychiatric phenotype of 22q11.2 deletion syndrome [abstract]. Am J Hum Genet 2003, 73:A555.Google Scholar
  17. 17.
    van Amelsvoort T, Henry J, Morris R, et al.: Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res 2004, 70:223–232.PubMedCrossRefGoogle Scholar
  18. 18.
    Chow EW, Watson M, Young DA, Bassett AS: Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res 2006, 87:270–278.PubMedCrossRefGoogle Scholar
  19. 19.
    Raux G, Bumsel E, Hecketsweiler B, et al.: Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 2007, 16:83–91.PubMedCrossRefGoogle Scholar
  20. 20.
    van Amelsvoort T, Daly E, Henry J, et al.: Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry 2004, 61:1085–1096.PubMedCrossRefGoogle Scholar
  21. 21.
    Gothelf D, Penniman L, Gu E, et al.: Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study. Schizophr Res 2007, 96:72–81.PubMedCrossRefGoogle Scholar
  22. 22.
    Chow EW, Mikulis DJ, Zipursky RB, et al.: Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 1999, 46:1436–1442.PubMedCrossRefGoogle Scholar
  23. 23.
    Chow EW, Zipursky RB, Mikulis DJ, Bassett AS: Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry 2002, 51:208–215.PubMedCrossRefGoogle Scholar
  24. 24.
    Kiehl TR, Chow EW, Mikulis D, Bassett AS: Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb Cortex 2008, In press.Google Scholar
  25. 25.
    Meechan DW, Maynard TM, Gopalakrishna D, et al.: When half is not enough: gene expression and dosage in the 22q11 deletion syndrome. Gene Expr 2007, 13:299–310.PubMedCrossRefGoogle Scholar
  26. 26.
    Amati F, Biancolella M, Farcomeni A, et al.: Dynamic changes in gene expression profiles of 22q11 and related orthologous genes during mouse development. Gene 2007, 391:91–102.PubMedCrossRefGoogle Scholar
  27. 27.
    Lewis CM, Levinson DF, Wise LH, et al.: Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003, 73:34–48.PubMedCrossRefGoogle Scholar
  28. 28.
    Badner JA, Gershon ES: Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405–411.PubMedCrossRefGoogle Scholar
  29. 29.
    Hamshere ML, Bennett P, Williams N, et al.: Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005, 62:1081–1088.PubMedCrossRefGoogle Scholar
  30. 30.
    Arinami T: Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia. J Hum Genet 2006, 51:1037–1045.PubMedCrossRefGoogle Scholar
  31. 31.
    Demily C, Legallic S, Bou J, et al.: ZDHHC8 single nucleotide polymorphism rs175174 is not associated with psychiatric features of the 22q11 deletion syndrome or schizophrenia. Psychiatr Genet 2007, 17:311–312.PubMedCrossRefGoogle Scholar
  32. 32.
    Shifman S, Levit A, Chen ML, et al.: A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia. Hum Genet 2006, 120:160–170.PubMedCrossRefGoogle Scholar
  33. 33.
    Paylor R, Lindsay E: Mouse models of 22q11 deletion syndrome. Biol Psychiatry 2006, 59:1172–1179.PubMedCrossRefGoogle Scholar
  34. 34.
    Funke BH, Lencz T, Finn CT, et al.: Analysis of TBX1 variation in patients with psychotic and affective disorders. Mol Med 2007, 13:407–414.PubMedCrossRefGoogle Scholar
  35. 35.
    Jungerius BJ, Hoogendoorn ML, Bakker SC, et al.: An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol Psychiatry 2007 [Epub ahead of print.]Google Scholar
  36. 36.
    Bassett AS, Caluseriu O, Weksberg R, et al.: Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry 2007, 61:1135–1140.PubMedCrossRefGoogle Scholar
  37. 37.
    Baker K, Baldeweg T, Sivagnanasundaram S, et al.: COMT Val(108/158)Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry 2005, 58:23–31.PubMedCrossRefGoogle Scholar
  38. 38.
    Guris DL, Duester G, Papaioannou VE, Imamoto A: Dose-dependent interaction of Tbx1 and Crk1 and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell 2006, 10:81–92.PubMedCrossRefGoogle Scholar
  39. 39.
    Zhang Z, Baldini A: In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum Mol Genet 2008, 17:150–157.PubMedCrossRefGoogle Scholar
  40. 40.
    Meechan DW, Maynard TM, Wu Y, et al.: Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. Mol Cell Neurosci 2006, 33:412–428.PubMedCrossRefGoogle Scholar
  41. 41.
    Sivagnanasundaram S, Fletcher D, Hubank M, et al.: Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia. Brain Res 2007, 1139:48–59.PubMedCrossRefGoogle Scholar
  42. 42.
    Gothelf D, Frisch A, Munitz H, et al.: Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am J Med Genet 1997, 72:455–461.PubMedCrossRefGoogle Scholar
  43. 43.
    Wiehahn GJ, Bosch GP, du Preez RR, et al.: Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2004, 129:20–22.PubMedCrossRefGoogle Scholar
  44. 44.
    Sugama S, Namihira T, Matsuoka R, et al.: Psychiatric inpatients and chromosome deletions within 22q11.2. J Neurol Neurosurg Psychiatry 1999, 67:803–806.PubMedGoogle Scholar
  45. 45.
    Murphy KC, Jones RG, Griffiths E, et al.: Chromosome 22q11 deletions. An under-recognised cause of idiopathic learning disability. Br J Psychiatry 1998, 172:180–183.PubMedCrossRefGoogle Scholar
  46. 46.
    Karayiorgou M, Morris MA, Morrow B, et al.: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 1995, 92:7612–7616.PubMedCrossRefGoogle Scholar
  47. 47.
    Pawlowska B, Tomankiewicz-Zawadzka A, Ilnicka A, et al.: A study on the occurrence of the deletion 22q11.2 in patients affected with a psychiatric disease [in Polish]. Psychiatr Pol 2007, 41:251–260.PubMedGoogle Scholar
  48. 48.
    Horowitz A, Shifman S, Rivlin N, et al.: A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 2005, 73:263–267.PubMedCrossRefGoogle Scholar
  49. 49.
    Arinami T, Ohtsuki T, Takase K, et al.: Screening for 22q11 deletions in a schizophrenia population. Schizophr Res 2001, 52:167–170.PubMedCrossRefGoogle Scholar
  50. 50.
    Ivanov D, Kirov G, Norton N, et al.: Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis. Molecular genetic study. Br J Psychiatry 2003, 183:409–413.PubMedCrossRefGoogle Scholar
  51. 51.
    Chen CH, Lee YR, Chung MY, et al.: Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. Am J Psychiatry 1999, 156:1273–1275.PubMedGoogle Scholar
  52. 52.
    Hoogendoorn ML, Vorstman JA, Jalali GR, et al.: Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res 2008, 98:84–88.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  1. 1.Centre for Addiction and Mental HealthTorontoCanada

Personalised recommendations